Cargando…
Analgesic Efficacy and Safety of Intravenous Meloxicam in Subjects With Moderate-to-Severe Pain After Open Abdominal Hysterectomy: A Phase 2 Randomized Clinical Trial
An intravenous (IV) formulation of meloxicam was developed for moderate-to-severe pain management. This study evaluated the safety and efficacy of meloxicam IV after open abdominal hysterectomy. Meloxicam IV is an investigational product not yet approved by the US Food and Drug Administration. METHO...
Autores principales: | Rechberger, Tomasz, Mack, Randall J., McCallum, Stewart W., Du, Wei, Freyer, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530966/ https://www.ncbi.nlm.nih.gov/pubmed/31094806 http://dx.doi.org/10.1213/ANE.0000000000003920 |
Ejemplares similares
-
Safety and efficacy of an intravenous nanocrystal formulation of meloxicam in the management of moderate to severe pain following laparoscopic abdominal surgery
por: Singla, Neil, et al.
Publicado: (2018) -
Efficacy and Safety of Intravenous Meloxicam in Subjects with Moderate-to-severe Pain Following Abdominoplasty
por: Singla, Neil, et al.
Publicado: (2018) -
Safety and Efficacy of Perioperative Intravenous Meloxicam for Moderate-to-Severe Pain Management in Total Knee Arthroplasty: A Randomized Clinical Trial
por: Berkowitz, Richard D, et al.
Publicado: (2021) -
Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty
por: Bindewald, Matthew, et al.
Publicado: (2017) -
Evaluation of the safety and efficacy of an intravenous nanocrystal formulation of meloxicam in the management of moderate-to-severe pain after bunionectomy
por: Gottlieb, Ira J, et al.
Publicado: (2018)